Diaceutics 

$1.67
5
+$0+0% Thursday 15:49

統計

當日最高
1.37
當日最低
1.37
52週高點
2.51
52週低點
1.37
成交量
17,746
平均成交量
16
市值
141.64M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

24Mar預期
Q1 2024
Q2 2024
Q4 2024
Q1 2025
Q2 2025
Q4 2025
下一步
-3.65
-0.93
1.78
4.5
預期EPS
3.0596555584000003
實際EPS
不適用

財務

-5.33%利潤率
未盈利
2019
2020
2021
2022
2023
2024
80.67M營收
-4.3M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 DIUXF 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Show more...
執行長
Mr. Peter Keeling
員工
184
國家
IE
ISIN
GB00BJQTGV64

上市

0 Comments

分享你的想法

FAQ

Diaceutics 今天的股價是多少?
DIUXF 目前價格為 $1.67 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Diaceutics 股價表現。
Diaceutics 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Diaceutics 的股票以代號 DIUXF 進行交易。
Diaceutics 的股價在上漲嗎?
DIUXF 股票較上週上漲 +0%,本月上漲 +0%,過去一年 Diaceutics 上漲 +22.15%。
Diaceutics 的市值是多少?
今天 Diaceutics 的市值為 141.64M
Diaceutics 下一次財報日期是什麼時候?
Diaceutics 將於 September 29, 2026 公布下一次財報。
Diaceutics 去年的營收是多少?
Diaceutics 去年的營收為 80.67MUSD。
Diaceutics 去年的淨利是多少?
DIUXF 去年的淨收益為 -4.3MUSD。
Diaceutics 有多少名員工?
截至 April 01, 2026,公司共有 184 名員工。
Diaceutics 位於哪個產業?
Diaceutics從事於Health Care產業。
Diaceutics 何時完成拆股?
Diaceutics 最近沒有進行任何拆股。
Diaceutics 的總部在哪裡?
Diaceutics 的總部位於 IE 的 Belfast。